Assessing the impact of prostate cancer prevention and detection initiatives

Prostate cancer is the most common male malignancy, yet prevention and early detection efforts show inconsistent uptake worldwide.

To identify which strategies and contextual factors enhance, or hinder, the effectiveness of prostate cancer prevention and screening.

An integrative review yielded 19 peer-reviewed studies. Quality was appraised using Critical Appraisal Skills Programme; data were thematically synthesised.

Five themes surfaced. (1) Cultural attitudes-fear of digital rectal examination reduces participation, but tailored messaging can overcome this resistance. (2) Chemoprevention-finasteride and dutasteride cut incidence of prostrate cancer by ≈25 %, however, there are side effects which must be managed. (3) Biomarkers-the prostate-specific antigen test is the most widely used screening test, but the prostate cancer antigen 3 test is more accurate but increases costs. (4) Access models-mobile units, mass screening and theory-based education triple to six-fold prostate-specific antigen uptake in under-served groups, showing that low-barrier delivery can offset stigma. (5) Lifestyle-low-fat diets and micronutrients offer modest protection against prostate cancer, while obesity raises high-grade risk, highlighting synergy between behavioural and clinical interventions.

Integrating accurate diagnostics, culturally sensitive education, low-barrier outreach and lifestyle counselling offers the strongest pathway to equitable, sustainable prostate cancer control. Future studies should evaluate cost effectiveness and long-term adherence in diverse settings.